These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25820125)

  • 1. Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapy.
    Nemani KV; Ennis RC; Griswold KE; Gimi B
    J Biotechnol; 2015 Jun; 203():32-40. PubMed ID: 25820125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alginate microencapsulation on the catalytic efficiency and in vitro enzyme-prodrug therapeutic efficacy of cytosine deaminase and of recombinant E. coli expressing cytosine deaminase.
    Funaro MG; Nemani KV; Chen Z; Bhujwalla ZM; Griswold KE; Gimi B
    J Microencapsul; 2016 Feb; 33(1):64-70. PubMed ID: 26642874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
    Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
    Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilizing Alginate Confinement and Polymer Coating of CO-Releasing Molecules Supported on Iron Oxide Nanoparticles To Trigger the CO Release by Magnetic Heating.
    Meyer H; Winkler F; Kunz P; Schmidt AM; Hamacher A; Kassack MU; Janiak C
    Inorg Chem; 2015 Dec; 54(23):11236-46. PubMed ID: 26595858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference.
    Mahan SD; Ireton GC; Stoddard BL; Black ME
    Biochemistry; 2004 Jul; 43(28):8957-64. PubMed ID: 15248753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
    Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
    J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically engineered theranostic mesenchymal stem cells for the evaluation of the anticancer efficacy of enzyme/prodrug systems.
    Nouri FS; Wang X; Hatefi A
    J Control Release; 2015 Feb; 200():179-87. PubMed ID: 25575867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R; Cohen S; Atkinson G; Hall SJ
    J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of Aspergillus parasiticus cytosine deaminase by immobilization on calcium alginate beads improved enzyme operational stability.
    Zanna H; Nok AJ; Ibrahim S; Inuwa HM
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1217-20. PubMed ID: 23030840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
    You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
    Van Rite BD; Harrison RG
    Cancer Lett; 2011 Aug; 307(1):53-61. PubMed ID: 21546157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli cytosine deaminase: Structural and biotechnological aspects.
    Vosough P; Vafadar A; Naderi S; Alashti SK; Karimi S; Irajie C; Savardashtaki A; Taghizadeh S
    Biotechnol Appl Biochem; 2024 Feb; 71(1):5-16. PubMed ID: 37743549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
    J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.
    Fox ME; Lemmon MJ; Mauchline ML; Davis TO; Giaccia AJ; Minton NP; Brown JM
    Gene Ther; 1996 Feb; 3(2):173-8. PubMed ID: 8867865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of a novel chitosan based E. coli cytosine deaminase nanocomposite for potential application in prodrug enzyme therapy.
    Yata VK; Ghosh SS
    Biotechnol Lett; 2011 Jan; 33(1):153-7. PubMed ID: 20960222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
    Kaliberov SA; Market JM; Gillespie GY; Krendelchtchikova V; Della Manna D; Sellers JC; Kaliberova LN; Black ME; Buchsbaum DJ
    Gene Ther; 2007 Jul; 14(14):1111-9. PubMed ID: 17495948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
    Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
    Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
    Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
    Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosine deaminase/5-fluorocytosine exposure induces bystander and radiosensitization effects in hypoxic glioblastoma cells in vitro.
    Chen JK; Hu LJ; Wang D; Lamborn KR; Deen DF
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1538-47. PubMed ID: 17394949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.